The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients.
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
J
J
Boysen
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
S
S
Sinha
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
T
T
Price-Troska
Tolero Pharmaceuticals Inc., Salt Lake City, UT, USA.
S L
SL
Warner
Tolero Pharmaceuticals Inc., Salt Lake City, UT, USA.
D J
DJ
Bearss
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
D
D
Viswanatha
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
T D
TD
Shanafelt
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
N E
NE
Kay
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
A K
AK
Ghosh
D020413:3' Untranslated Regions; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D034622:RNA Interference; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism; D000094963:Axl Receptor Tyrosine Kinase
D020413:3' Untranslated Regions; C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; D020794:Receptor Protein-Tyrosine Kinases; D000094963:Axl Receptor Tyrosine Kinase; C000722289:AXL protein, human